Tonix Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $3,290 | $1,998 | $2,429 | $2,582 |
Gross Profit | 1,923 | -1,274 | 1,486 | 1,399 |
EBITDA | -31,548 | -27,813 | -16,336 | -21,612 |
EBIT | -32,009 | -28,296 | -16,829 | -22,108 |
Net Income | -32,009 | -28,272 | -16,829 | -22,108 |
Net Change In Cash | 3,290 | 1,998 | 2,429 | 2,582 |
Free Cash Flow | -29,744 | -17,372 | -16,585 | -14,633 |
Cash | 190,055 | 125,331 | 131,716 | 98,776 |
Basic Shares | 8,922 | 7,327 | 5,927 | 2,263 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,094 | $7,768 | $9,027 | $0 |
Gross Profit | 2,329 | 3,027 | -112,091 | -92,312 |
EBITDA | -74,323 | -114,089 | -110,838 | -92,262 |
EBIT | -77,744 | -118,380 | -112,091 | -92,312 |
Net Income | -130,036 | -116,658 | -115,004 | -92,212 |
Net Change In Cash | 10,094 | 7,768 | 9,027 | 0 |
Cost of Revenue | 101,623 | |||
Free Cash Flow | -61,045 | -109,898 | -146,200 | -110,864 |
Cash | 98,776 | 24,948 | 120,229 | 178,660 |
Basic Shares | 736 | 7 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$3.59 |
2025-06-30 | -$3.86 |
2025-03-31 | -$2.64 |
